Ads
related to: clinical trials phases
Search results
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively...
Digital Journal· 17 hours agoAdaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell ...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 5 hours agoOther drugs targeting LAG-3 are being trialled for the treatment of multiple myeloma, oesophagal and...
Aprea advances cancer drug ATRN-119 in clinical trial By Investing.com
Investing.com· 3 days agoAprea Therapeutics, Inc. (NASDAQ:APRE), a biopharmaceutical company, has announced progression in...
Merck stock climbs as breast cancer Phase 3 trial data meets endpoint By Investing.com
Investing.com· 3 days agoMerck & Co (MRK) announced on Tuesday that its phase 3 KEYNOTE-522 trial evaluating Keytuda...
Novartis’ atrasentan shows to reduce proteinuria in Phase III IgAN trial
Clinical Trials Arena via Yahoo Finance· 4 days agoNovartis has unveiled interim results from the Phase III ALIGN clinical trial where atrasentan...
Groundbreaking human trial for tooth regeneration drug set to begin
The Washington Times· 21 hours agoThe world’s first clinical trial of a drug designed to regenerate human teeth is slated to start in...
...Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating...
WTNH-TV New Haven· 4 days agoCLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 3 days agoGlobalData is the parent company of the Clinical Trials Arena. "Transcenta’s Osemitamab succeeds in ...
InxMed Reports Positive Phase Ib/II Results for Ifebemtinib in Combination with Garsorasib in...
WKBN 27 Youngstown· 1 day ago...modalities NANJING, China, May 30, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against tumor-treatment resistance and metastasis, today announced results from the Phase Ib/II clinical trial of ifebemtinib, the company's focal...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...